Documento fuente o registro público

FDA 510(k) K252357 — Glucose2

FDA 510(k) index record K252357. Device: Glucose2. Applicant as listed: Abbott Ireland. Decision date: 2025-10-24.

OtherU.S. Food and Drug Administration (FDA)2025-10-24

Fuente

"device_name": "Glucose2"
api.fda.gov · Consultado el 2026-10-23

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-24

Disclaimer

professional use

References

FDA 510(k) public index record K252357.

Device name: Glucose2. Applicant as listed: Abbott Ireland.

Decision date: 2025-10-24. Decision wording: Substantially Equivalent.

Product code: CFR. Regulation: 21 CFR 862.1345. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Solicitar cotización

FDA 510(k) K252357 — Glucose2

Fuente

Review and references

Interested in these solutions?

Explorar más

FDA 510(k) K262432 — CorDx Tyfast Flu A/B & COVID-19 At Home Multiplex Rapid Test; CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test

FDA 510(k) K262576 — twiist Loop Algorithm

FDA 510(k) K260827 — Oncomine Dx Express Test

Fuente

Review and references

Interested in these solutions?

Explorar más

FDA 510(k) K262432 — CorDx Tyfast Flu A/B & COVID-19 At Home Multiplex Rapid Test; CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test

FDA 510(k) K262576 — twiist Loop Algorithm

FDA 510(k) K260827 — Oncomine  Dx Express Test

FDA 510(k) K260827 — Oncomine Dx Express Test